Lowest Price Guaranteed From USD 5,899
Published
March 2022
Pages
210
View Count
5141
Example Insights
 |
 |
 |
 |
 |
 |
 |
 |
 |
Report Description
On an average, around 50 drugs are approved by the US Food and Drug Administration (US FDA) annually. Further, studies indicate that more than 100,000 tons of pharmaceutical products are consumed globally per year. In addition, over the next five years, the global pharmaceutical market is projected to grow at a CAGR of 4.7%, with global drug sales anticipated to raise revenues worth USD 1.5 trillion in 2023. This continuously growing pipeline of pharmaceutical drug products has inadvertently led to an increase in the demand for their associated primary packaging and secondary packaging solutions. Specifically, pharmaceutical secondary packaging is a vital step in the product supply chain as it encloses life-saving drugs and therapies, preserving the identity, quality, integrity and stability of the packaged drug product. It also plays a key role in marketing and brand projection for a product. However, the process of secondary packaging usually involves time consuming and complex activities, such as blister carding, thermoforming, labeling, kitting, assembly and cold chain storage (for temperature sensitive biologics). Other key challenges faced by developers are limiting variability in packaging materials and ensuring compliance to stringent regulatory guidelines (for packaging designs). Considering the aforementioned concerns, many pharmaceutical players now prefer to collaborate with qualified packaging providers that offer non-traditional packaging solutions and have the required capabilities to create unique packaging designs, in a cost and time effective manner.
As per the CDMO Outsourcing Survey conducted by Nice Insight, specifically for clinical and commercial scale operations, nearly 60% of the pharmaceutical companies currently outsource their primary packaging needs, while 43% of the players outsource their secondary packaging requirements. At present, more than 160 companies offer secondary packaging solutions to the firms engaged in the pharmaceutical sector. Further, several recent advancements in packaging designs, technologies and materials have enabled service providers to offer a wide range of user-friendly pharmaceutical secondary packaging solutions. In addition, substantial expansions, mergers and acquisitions, and partnerships have been reported in this market as service providers strive to become one-stop-shops, in order to cater to the diverse needs of their clients engaged in the healthcare industry. Driven by the ongoing innovation in this field, continuous growth in the pharmaceutical drugs pipeline and a steady rise in drug approvals, the pharmaceutical secondary packaging market is likely to witness positive growth in the foreseen future.
The ‘Pharmaceutical Secondary Packaging Market – Distribution by Type of Secondary Packaging (Boxes, Cartons and Pouches), Type of Primary Packaging Packed (Ampoules, Blister Packs, Bottles, Cartridges, Syringes and Vials) and Key Geographies (North America, Europe, Asia-Pacific, MENA, Latin America, and Rest of the World): Industry Trends and Global Forecasts, 2022-2035’ report features an extensive study of the current market landscape and future potential of the pharmaceutical secondary packaging market. The study features an in-depth analysis, highlighting the capabilities of pharmaceutical secondary packaging providers. Amongst other elements, the report features:
One of the key objectives of the report was to evaluate the current opportunity and future potential associated with the pharmaceutical secondary packaging market, over the coming 13 years. We have provided an informed estimates of the likely evolution of the market in the short to mid-term and long term, for the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented based on relevant parameters, such as [A] type of secondary packaging (boxes, cartons and others), [B] type of primary packaging packed (ampoules, blister packs, bottles, cartridges, syringes and vials) and [C] key geographical regions (North America, Europe, Asia-Pacific, MENA, Latin America and rest of the world). To account for future uncertainties in the market and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.
The opinions and insights presented in the report were also influenced by discussions held with senior stakeholders in the industry. The report features detailed transcripts of interviews held with the following individuals:
Contents
Chapter 2 is an executive summary of the key insights captured during our research. It offers a high-level view on the likely evolution of the pharmaceutical secondary packaging market in the short to mid-term, and long term.
Chapter 3 provides a general overview of pharmaceutical packaging and importance / need for packaging in the pharmaceutical industry. Further, it contains a brief introduction to pharmaceutical secondary packaging, different types of pharmaceutical secondary packaging solutions and importance of secondary packaging in the pharmaceutical industry. The chapter concludes with a discussion on the key opportunity areas for secondary packaging providers and inputs on their projected growth in the coming years.
Chapter 4 features a detailed review of the current market landscape of around 165 companies offering pharmaceutical secondary packaging services. Additionally, it features an in-depth analysis of service providers, based on a number of relevant parameters, such as year of establishment, company size (in terms of employee count), location of headquarters and scale of operation (preclinical, clinical and commercial). Further, the chapter also covers details about type of service provider (one-stop-shop service providers and stand-alone service providers), type of secondary packaging offered (cartons, boxes and others), type of primary packaging packed (blisters, vials, bottles, conventional syringes, ampoules, prefilled syringes and others), type of molecule packed (biologics, small molecules and unspecified), type of finished dosage form packed (solids, liquids / injectables, semi-solids, powders and others) and type of additional services offered (labeling, serialization, kitting and cold-chain storage).
Chapter 5 presents an insightful competitiveness analysis of the pharmaceutical secondary packaging providers, located in North America, Europe, and Asia-Pacific and rest of the world. The companies are further segmented based on their employee count, into three categories, namely small (1-200 employees), mid-sized (201-500 employees) and large (>500 employees) across these geographies. The analysis compares the service providers on the basis of various parameters, such as supplier power (in terms of years of experience), company competitiveness (type secondary packaging offered, type of primary packaging packed, type of molecule packed, type of finished dosage form packed, and type of additional services offered) and scale of operation (preclinical, clinical and commercial).
Chapter 6 consist of detailed profiles of the prominent players (shortlisted based on a proprietary criterion) that are engaged in offering pharmaceutical secondary packaging in North America. Each profile provides an overview of the company, its pharmaceutical secondary packaging offerings and details on recent developments, as well as an informed future outlook.
Chapter 7 consist of detailed profiles of the prominent players (shortlisted based on a proprietary criterion) that are engaged in offering pharmaceutical secondary packaging in Europe. Each profile provides an overview of the company, its pharmaceutical secondary packaging offerings and details on recent developments, as well as an informed future outlook.
Chapter 8 consist of detailed profiles of the prominent players (shortlisted based on a proprietary criterion) that are engaged in offering pharmaceutical secondary packaging in Asia-Pacific. Each profile provides an overview of the company, its pharmaceutical secondary packaging offerings and details on recent developments, as well as an informed future outlook.
Chapter 9 features an insightful analysis of the various partnerships and collaborations that have been inked by stakeholders engaged in this domain (since 2018). It includes a brief description of the partnership models (including acquisitions, manufacturing and packaging agreements, service alliances, packaging agreements, distribution agreements, technology utilization agreements and others) adopted by stakeholders in the domain of pharmaceutical secondary packaging. Further, it comprises of analysis based on several relevant parameters such as year of agreement, type of agreement, type of molecule packed, type of finished dosage form packed and most active players (in terms of number of partnerships). Further, the chapter includes a world map representation of all the deals inked in this field in the period 2018-2021, highlighting both intercontinental and intracontinental partnership activity.
Chapter 10 presents a detailed analysis of the recent expansions undertaken (since 2018) by various pharmaceutical secondary packaging providers, based on several relevant parameters, such as year of expansion, type of expansion (capacity expansion, facility expansion and new facility), scale of operation (preclinical, clinical and commercial), type of primary packaging packed (blisters, bottles, syringes, vials, ampoules, sachets), type of molecule packed (biologics and small molecules), type of finished dosage form packed (solids and liquids), company size (in terms of employee count), location of headquarters (North America, Europe, Asia-Pacific and rest of the world), location of expanded facility, most active players (in terms of number of recent expansions) and geographical distribution (region-wise and country-wise).
Chapter 11 includes an in-depth analysis in order to estimate the current and future demand for pharmaceutical secondary packaging, based on several relevant parameters, such as type of secondary packaging (boxes, cartons and pouches), type of primary packaging packed (ampoules, blister packs, bottles, cartridges, syringes and vials) and key geographical regions (North America, Europe, Asia-Pacific, MENA, Latin America and rest of the world), for the period 2022-2035.
Chapter 12 presents an insightful market forecast analysis, highlighting the likely growth of the pharmaceutical secondary packaging market, for the period 2022-2035. Additionally, the report features the likely distribution of the current and forecasted opportunity across various relevant parameters such as [A] type of secondary packaging (boxes, cartons and others), [B] type of primary packaging packed (ampoules, blister packs, bottles, cartridges, syringes and vials) and [C] key geographical regions (North America, Europe, Asia-Pacific, MENA, Latin America and rest of the world).
Chapter 13 summarizes the overall report. In this chapter, we have provided a list of key takeaways from the report, and expressed our independent opinion related to the research and analysis described in the previous chapters.
Chapter 14 provides the transcripts of the interviews conducted with representatives from renowned organizations that are engaged in providing pharmaceutical secondary packaging. The chapter contains the details of our conversation with Jake Aspinall (Commercial Director, Active Pharma Supplies), Silvio Del Deo (Managing Director, Depo Pack) and Joe Luke (Vice President, Sales and Marketing, Reed-Lane).
Chapter 15 is an appendix, that provides tabulated data and numbers for all the figures included in the report.
Chapter 16 is an appendix that provides the list of companies and organizations that have been mentioned in the report.
Table Of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Research Methodology
1.3. Key Questions Answered
1.4. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Pharmaceutical Packaging
3.2.1. Key Attributes of Pharmaceutical Packaging
3.2.2. Types of Pharmaceutical Packaging
3.3. Introduction to Pharmaceutical Secondary Packaging
3.3.1 Types of Secondary Packaging Used in the Pharmaceutical Industry
3.3.2 Importance / Need for Secondary Packaging
3.4. Concluding Remarks
4. COMPETITIVE LANDSCAPE
4.1. Chapter Overview
4.2. Pharmaceutical Secondary Packaging Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Scale of Operation
4.2.5. Analysis by Type of Service Provider
4.2.6. Analysis by Type of Secondary Packaging Offered
4.2.7. Analysis by Type of Primary Packaging Packed
4.2.8. Analysis by Type of Molecule Packed
4.2.9. Analysis by Type of Finished Dosage Form Packed
4.2.10. Analysis by Types of Additional Services Offered
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Company Competitiveness Analysis: Pharmaceutical Secondary Packaging Providers
5.4.1. Pharmaceutical Secondary Packaging Providers in North America
5.4.1.1. Competitiveness Analysis: Small Companies in North America
5.4.1.2. Competitiveness Analysis: Mid-sized Companies in North America
5.4.1.3. Competitiveness Analysis: Large Companies in North America
5.4.2. Pharmaceutical Secondary Packaging Providers in Europe
5.4.2.1. Competitiveness Analysis: Small Companies in Europe
5.4.2.2. Competitiveness Analysis: Mid-sized Companies in Europe
5.4.2.3. Competitiveness Analysis: Large Companies in Europe
5.4.3. Pharmaceutical Secondary Packaging Providers in Asia-Pacific and Rest of the World
5.4.3.1. Competitiveness Analysis: Small Companies in Asia-Pacific and Rest of the World
5.4.3.2. Competitiveness Analysis: Mid-sized Companies in Asia-Pacific and Rest of the World
5.4.3.3. Competitiveness Analysis: Large Companies in Asia-Pacific and Rest of the World
6. COMPANY PROFILES: PHARMACEUTICAL SECONDARY PACKAGING PROVIDERS IN NORTH AMERICA
6.1. Chapter Overview
6.2. Catalent
6.2.1. Company Overview
6.2.2. Pharmaceutical Secondary Packaging Offerings
6.2.3. Recent Developments and Future Outlook
6.3. Patheon (By Thermo Fisher Scientific)
6.3.1. Company Overview
6.3.2. Pharmaceutical Secondary Packaging Offerings
6.3.3. Recent Developments and Future Outlook
6.4. PCI Pharma Services
6.4.1. Company Overview
6.4.2. Pharmaceutical Secondary Packaging Offerings
6.4.3. Recent Developments and Future Outlook
6.5. Pfizer CentreOne
6.5.1. Company Overview
6.5.2. Pharmaceutical Secondary Packaging Offerings
6.5.3. Recent Developments and Future Outlook
6.6. Sharp
6.6.1. Company Overview
6.6.2. Pharmaceutical Secondary Packaging Offerings
6.6.3. Recent Developments and Future Outlook
7. COMPANY PROFILES: PHARMACEUTICAL SECONDARY PACKAGING PROVIDERS IN EUROPE
7.1. Chapter Overview
7.2. Almac Group
7.2.1. Company Overview
7.2.2. Pharmaceutical Secondary Packaging Offerings
7.2.3. Recent Developments and Future Outlook
7.3. Central Pharma
7.3.1. Company Overview
7.3.2. Pharmaceutical Secondary Packaging Offerings
7.3.3. Recent Developments and Future Outlook
7.4. CordenPharma
7.4.1. Company Overview
7.4.2. Pharmaceutical Secondary Packaging Offerings
7.4.3. Recent Developments and Future Outlook
7.5. Eurofins CDMO
7.5.1. Company Overview
7.5.2. Pharmaceutical Secondary Packaging Offerings
7.5.3. Recent Developments and Future Outlook
7.6. Tjoapack
7.6.1. Company Overview
7.6.2. Pharmaceutical Secondary Packaging Offerings
7.6.3. Recent Developments and Future Outlook
8. COMPANY PROFILES: PHARMACEUTICAL SECONDARY PACKAGING PROVIDERS IN ASIA-PACIFIC
8.1. Chapter Overview
8.2. ABS (Australian Blister Sealing)
8.2.1. Company Overview
8.2.2. Pharmaceutical Secondary Packaging Offerings
8.2.3. Recent Developments and Future Outlook
8.3. Bushu Pharma
8.3.1. Company Overview
8.3.2. Pharmaceutical Secondary Packaging Offerings
8.3.3. Recent Developments and Future Outlook
8.4. CMIC
8.4.1. Company Overview
8.4.2. Pharmaceutical Secondary Packaging Offerings
8.4.3. Recent Developments and Future Outlook
8.5. Kishore group
8.5.1. Company Overview
8.5.2. Pharmaceutical Secondary Packaging Offerings
8.5.3. Recent Developments and Future Outlook
8.6. Prince Art Packages
8.6.1. Company Overview
8.6.2. Pharmaceutical Secondary Packaging Offerings
8.6.3. Recent Developments and Future Outlook
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. Pharmaceutical Secondary Packaging Providers: Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Year and Type of Partnership
9.3.4. Analysis by Type of Molecule Packed
9.3.5. Analysis by Type of Finished Dosage Form Packed
9.3.6. Most Active Players: Analysis by Number of Partnerships
9.3.7. Geographical Analysis
9.3.7.1. Intercontinental and Intracontinental Deals
9.3.8.2. International and Local Deals
10. RECENT EXPANSIONS
10.1. Chapter Overview
10.2. Pharmaceutical Secondary Packaging Providers: Recent Expansions
10.2.1. Analysis by Year of Expansion
10.2.2. Analysis by Type of Expansion
10.2.3. Analysis by Scale of Operation
10.2.4. Analysis by Type of Expansion and Scale of Operation
10.2.5. Analysis by Type of Primary Packaging Packed
10.2.6. Analysis by Type of Molecule Packed
10.2.7. Analysis by Type of Expansion and Type of Molecule Packed
10.2.8. Analysis by Type of Finished Dosage Form Packed
10.2.9. Analysis by Company Size and Location of Headquarters
10.2.10. Analysis by Location of Expanded Facility
10.2.11. Analysis by Type of Expansion and Location of Expanded Facility
10.2.12. Most Active Players: Analysis by Number of Recent Expansions
10.2.13. Geographical Analysis
10.2.13.1. Region-wise Distribution
10.2.13.2. Country-wise Distribution
11. DEMAND ANALYSIS
11.1. Chapter Overview
11.2. Key Assumptions and Methodology
11.3. Global Demand for Pharmaceutical Secondary Packaging, 2022-2035
11.3.1. Analysis by Type of Secondary Packaging
11.3.1.1. Global Demand for Pharmaceutical Secondary Packaging Boxes, 2022-2035
11.3.1.2. Global Demand for Pharmaceutical Secondary Packaging Cartons, 2022-2035
11.3.1.3. Global Demand for Pharmaceutical Secondary Packaging Pouches, 2022-2035
11.3.2. Analysis by Type of Primary Packaging Packed
11.3.2.1. Global Demand for Ampoules, 2022-2035
11.3.2.2. Global Demand for Blister Packs, 2022-2035
11.3.2.3. Global Demand for Bottles, 2022-2035
11.3.2.4. Global Demand for Cartridges, 2022-2035
11.3.2.5. Global Demand for Syringes, 2022-2035
11.3.2.6. Global Demand for Vials, 2022-2035
11.3.3. Analysis by Geography
11.3.3.1. Demand for Pharmaceutical Secondary Packaging in North America, 2022-2035
11.3.3.1.1. Demand for Pharmaceutical Secondary Packaging Boxes in North America, 2022-2035
11.3.3.1.2. Demand for Pharmaceutical Secondary Packaging Cartons in North America, 2022-2035
11.3.3.1.3. Demand for Pharmaceutical Secondary Packaging Pouches in North America, 2022-2035
11.3.3.2. Demand for Pharmaceutical Secondary Packaging in Europe, 2022-2035
11.3.3.2.1. Demand for Pharmaceutical Secondary Packaging Boxes in Europe, 2022-2035
11.3.3.2.2. Demand for Pharmaceutical Secondary Packaging Cartons in Europe, 2022-2035
11.3.3.3.3. Demand for Pharmaceutical Secondary Packaging Pouches in Europe, 2022-2035
11.3.3.3. Demand for Pharmaceutical Secondary Packaging in Asia-Pacific, 2022-2035
11.3.3.3.1. Demand for Pharmaceutical Secondary Packaging Boxes in Asia-Pacific, 2022-2035
11.3.3.3.2. Demand for Pharmaceutical Secondary Packaging Cartons in Asia-Pacific, 2022-2035
11.3.3.3.3. Demand for Pharmaceutical Secondary Packaging Pouches in Asia-Pacific, 2022-2035
11.3.3.4. Demand for Pharmaceutical Secondary Packaging in MENA, 2022-2035
11.3.3.4.1. Demand for Pharmaceutical Secondary Packaging Boxes in MENA, 2022-2035
11.3.3.4.2. Demand for Pharmaceutical Secondary Packaging Cartons in MENA, 2022-2035
11.3.3.4.3. Demand for Pharmaceutical Secondary Packaging Pouches in MENA, 2022-2035
11.3.3.5. Demand for Pharmaceutical Secondary Packaging in Latin America, 2022-2035
11.3.3.5.1. Demand for Pharmaceutical Secondary Packaging Boxes in Latin America, 2022-2035
11.3.3.5.2. Demand for Pharmaceutical Secondary Packaging Cartons in Latin America, 2022-2035
11.3.3.5.3. Demand for Pharmaceutical Secondary Packaging Pouches in Latin America, 2022-2035
11.3.3.6. Demand for Pharmaceutical Secondary Packaging in Rest of the World, 2022-2035
11.3.3.6.1. Demand for Pharmaceutical Secondary Packaging Boxes in Rest of the World, 2022-2035
11.3.3.6.2. Demand for Pharmaceutical Secondary Packaging Cartons in Rest of the World, 2022-2035
11.3.3.6.3. Demand for Pharmaceutical Secondary Packaging Pouches in Rest of the World, 2022-2035
12. MARKET FORECAST AND OPPORTUNITY ANALYSIS
12.1. Chapter Overview
12.2. Key Assumptions and Forecast Methodology
12.3. Global Pharmaceutical Secondary Packaging Market, 2022-2035
12.3.1. Pharmaceutical Secondary Packaging Market: Distribution by Type of Secondary Packaging, 2022 and 2035
12.3.1.1. Pharmaceutical Secondary Packaging Market for Boxes, 2022-2035
12.3.1.2. Pharmaceutical Secondary Packaging Market for Cartons, 2022-2035
12.3.1.3. Pharmaceutical Secondary Packaging Market for Pouches, 2022-2035
12.3.2. Pharmaceutical Secondary Packaging Market: Distribution by Type of Primary Packaging Packed, 2022 and 2035
12.3.2.1. Pharmaceutical Secondary Packaging Market for Ampoules, 2022-2035
12.3.2.2. Pharmaceutical Secondary Packaging Market for Blister Packs, 2022-2035
12.3.2.3. Pharmaceutical Secondary Packaging Market for Bottles, 2022-2035
12.3.2.4. Pharmaceutical Secondary Packaging Market for Cartridges, 2022-2035
12.3.2.5. Pharmaceutical Secondary Packaging Market for Syringes, 2022-2035
12.3.2.6. Pharmaceutical Secondary Packaging Market for Vials, 2022-2035
12.3.3. Pharmaceutical Secondary Packaging Market: Distribution by Geography, 2022-2035
12.3.3.1. Pharmaceutical Secondary Packaging Market in North America, 2022 and 2035
12.3.3.1.1. Pharmaceutical Secondary Packaging Market for Boxes in North America, 2022-2035
12.3.3.1.2. Pharmaceutical Secondary Packaging Market for Cartons in North America, 2022-2035
12.3.3.1.3. Pharmaceutical Secondary Packaging Market for Pouches, in North America, 2022-2035
12.3.3.2. Pharmaceutical Secondary Packaging Market in Europe, 2022 and 2035
12.3.3.2.1. Pharmaceutical Secondary Packaging Market for Boxes in Europe, 2022-2035
12.3.3.2.2. Pharmaceutical Secondary Packaging Market for Cartons in Europe, 2022-2035
12.3.3.2.3. Pharmaceutical Secondary Packaging Market for Pouches in Europe, 2022-2035
12.3.3.3. Pharmaceutical Secondary Packaging Market in Asia-Pacific, 2022 and 2035
12.3.3.3.1. Pharmaceutical Secondary Packaging Market for Boxes in Asia-Pacific, 2022-2035
12.3.3.3.2. Pharmaceutical Secondary Packaging Market for Cartons in Asia-Pacific, 2022-2035
12.3.3.3.3. Pharmaceutical Secondary Packaging Market for Pouches in Asia-Pacific, 2022-2035
12.3.3.4. Pharmaceutical Secondary Packaging Market in MENA, 2022 and 2035
12.3.3.4.1. Pharmaceutical Secondary Packaging Market for Boxes in MENA, 2022-2035
12.3.3.4.2. Pharmaceutical Secondary Packaging Market for Cartons in MENA, 2022-2035
12.3.3.4.3. Pharmaceutical Secondary Packaging Market for Pouches in MENA, 2022-2035
12.3.3.5. Pharmaceutical Secondary Packaging Market in Latin America, 2022 and 2035
12.3.3.5.1. Pharmaceutical Secondary Packaging Market for Boxes in Latin America, 2022-2035
12.3.3.5.2. Pharmaceutical Secondary Packaging Market for Cartons in Latin America, 2022-2035
12.3.3.5.3. Pharmaceutical Secondary Packaging Market for Pouches in Latin America, 2022-2035
12.3.3.6. Pharmaceutical Secondary Packaging Market in Rest of the World, 2022 and 2035
12.3.3.6.1. Pharmaceutical Secondary Packaging Market for Boxes in Rest of the World, 2022-2035
12.3.3.6.2. Pharmaceutical Secondary Packaging Market for Cartons in Rest of the World, 2022-2035
12.3.3.6.3. Pharmaceutical Secondary Packaging Market for Pouches in Rest of the World, 2022-2035
13. CONCLUDING REMARKS
14. EXECUTIVE INSIGHTS
14.1. Chapter Overview
14.2. Active Pharma Supplies
14.2.1. Company Snapshot
14.2.2. Interview Transcript: Jake Aspinall, Commercial Director
14.3. Depo Pack
14.3.1. Company Snapshot
14.3.2. Interview Transcript: Silvio Del Deo, Managing Director
14.4. Reed-Lane
14.4.1. Company Snapshot
14.4.2. Interview Transcript: Joe Luke, Vice President, Sales and Marketing
15. APPENDIX 1: TABULATED DATA
16. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
Figure 2.1 Executive Summary: Overall Market Landscape
Figure 2.2 Executive Summary: Partnerships and Collaborations
Figure 2.3 Executive Summary: Recent Expansions
Figure 2.4 Executive Summary: Demand Analysis
Figure 2.5 Executive Summary: Market Forecast
Figure 3.1 Key Advantages of Pharmaceutical Packaging
Figure 3.2 Key Attributes of Pharmaceutical Packaging
Figure 3.3 Type of Pharmaceutical Packaging
Figure 3.4 Type of Packaging Products
Figure 3.5 Various Contents of Packaging Materials
Figure 4.1 Pharmaceutical Secondary Packaging Providers: Distribution by Year of Establishment
Figure 4.2 Pharmaceutical Secondary Packaging Providers: Distribution by Company Size
Figure 4.3 Pharmaceutical Secondary Packaging Providers: Distribution by Location of
Figure 4.4 Pharmaceutical Secondary Packaging Providers: Distribution by Location of Headquarters (Country-wise)
Figure 4.5 Pharmaceutical Secondary Packaging Providers: Distribution by Company Size and Location of Headquarters
Figure 4.6 Pharmaceutical Secondary Packaging Providers: Distribution by Scale of Operation
Figure 4.7 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Service Provider
Figure 4.8 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Secondary Packaging Offered
Figure 4.9 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Primary Packaging Packed
Figure 4.10 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Molecule Packed
Figure 4.11 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Finished Dosage Form Packed
Figure 4.12 Pharmaceutical Secondary Packaging Providers: Distribution by Types of Additional Services Offered
Figure 5.1 Company Competitiveness Analysis: Small Companies in North America
Figure 5.2 Company Competitiveness Analysis: Mid-sized Companies in North America
Figure 5.3 Company Competitiveness Analysis: Large Companies in North America
Figure 5.4 Company Competitiveness Analysis: Small Companies in Europe
Figure 5.5 Company Competitiveness Analysis: Mid-sized Companies in Europe
Figure 5.6 Company Competitiveness Analysis: Large Companies in Europe
Figure 5.7 Company Competitiveness Analysis: Small Companies in Asia-Pacific and Rest of the World
Figure 5.8 Company Competitiveness Analysis: Mid-sized Companies in Asia-Pacific and Rest of the World
Figure 5.9 Company Competitiveness Analysis: Large Companies in Asia-Pacific and Rest of the World
Figure 9.1 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2021
Figure 9.2 Partnerships and Collaborations: Distribution by Type of Partnership
Figure 9.3 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Figure 9.4 Partnerships and Collaborations: Distribution by Type of Partnership, 2018-2019 and 2020-2021
Figure 9.5 Partnerships and Collaborations: Distribution by Type of Molecule Packed
Figure 9.6 Partnerships and Collaborations: Distribution by Type of Finished Dosage Form Packed
Figure 9.7 Most Active Players: Distribution by Number of Partnerships
Figure 9.8 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
Figure 9.9 Partnerships and Collaborations: Distribution of International and Local Deals
Figure 10.1 Recent Expansions: Cumulative Year-wise Trend, 2018-2022
Figure 10.2 Recent Expansions: Distribution by Type of Expansion
Figure 10.3 Recent Expansions: Distribution by Scale of Operation
Figure 10.4 Recent Expansions: Distribution by Type of Expansion and Scale of Operation
Figure 10.5 Recent Expansions: Distribution by Type of Primary Packaging Packed
Figure 10.6 Recent Expansions: Distribution by Type of Molecule Packed
Figure 10.7 Recent Expansions: Distribution by Type of Expansion and Type of Molecule Packed
Figure 10.8 Recent Expansions: Distribution by Type of Finished Dosage Form Packed
Figure 10.9 Recent Expansions: Distribution by Company Size and Location of Headquarters
Figure 10.10 Recent Expansions: Distribution by Location of Expanded Facility
Figure 10.11 Recent Expansions: Distribution by Type of Expansion and Location of Expanded Facility
Figure 10.12 Most Active Players: Distribution by Number of Recent Expansions
Figure 10.13 Recent Expansions: Year-wise Trend by Geography, 2018-2022
Figure 10.14 Recent Expansions: Country-wise Distribution
Figure 11.1 Global Demand for Pharmaceutical Secondary Packaging, 2022-2035 (Billion Units)
Figure 11.2 Global Demand for Pharmaceutical Secondary Packaging: Distribution by Type of Secondary Packaging, 2022-2035 (Billion Units)
Figure 11.3 Global Demand for Pharmaceutical Secondary Packaging Boxes, 2022-2035 (Billion Units)
Figure 11.4 Global Demand for Pharmaceutical Secondary Packaging Cartons, 2022-2035 (Billion Units)
Figure 11.5 Global Demand for Pharmaceutical Secondary Packaging Pouches, 2022-2035 (Billion Units)
Figure 11.6 Global Demand for Pharmaceutical Secondary Packaging: Distribution by Type of Primary Packaging Packed, 2022 and 2035 (Billion Units)
Figure 11.7 Demand for Pharmaceutical Secondary Packaging of Ampoules, 2022-2035 (Billion Units)
Figure 11.8 Demand for Pharmaceutical Secondary Packaging of Blister Packs, 2022-2035 (Billion Units)
Figure 11.9 Demand for Pharmaceutical Secondary Packaging of Bottles, 2022-2035 (Billion Units)
Figure 11.10 Demand for Pharmaceutical Secondary Packaging of Cartridges, 2022-2035 (Billion Units)
Figure 11.11 Demand for Pharmaceutical Secondary Packaging of Syringes, 2022-2035 (Billion Units)
Figure 11.12 Demand for Pharmaceutical Secondary Packaging of Vials, 2022-2035 (Billion Units)
Figure 11.13 Global Demand for Pharmaceutical Secondary Packaging: Distribution by Geography, 2022 and 2035 (Billion Units)
Figure 11.14 Demand for Pharmaceutical Secondary Packaging in North America, 2022-2035 (Billion Units)
Figure 11.15 Demand for Pharmaceutical Secondary Packaging Boxes in North America, 2022-2035 (Billion Units)
Figure 11.16 Demand for Pharmaceutical Secondary Packaging Cartons in North America, 2022-2035 (Billion Units)
Figure 11.17 Demand for Pharmaceutical Secondary Packaging Pouches in North America, 2022-2035 (Billion Units)
Figure 11.18 Demand for Pharmaceutical Secondary Packaging in Europe, 2022-2035 (Billion Units)
Figure 11.19 Demand for Pharmaceutical Secondary Packaging Boxes in Europe, 2022-2035 (Billion Units)
Figure 11.20 Demand for Pharmaceutical Secondary Packaging Cartons in Europe, 2022-2035 (Billion Units)
Figure 11.21 Demand for Pharmaceutical Secondary Packaging Pouches in Europe, 2022-2035 (Billion Units)
Figure 11.22 Demand for Pharmaceutical Secondary Packaging in Asia-Pacific, 2022-2035 (Billion Units)
Figure 11.23 Demand for Pharmaceutical Secondary Packaging Boxes in Asia-Pacific, 2022-2035 (Billion Units)
Figure 11.24 Demand for Pharmaceutical Secondary Packaging Cartons in Asia-Pacific, 2022-2035 (Billion Units)
Figure 11.25 Demand for Pharmaceutical Secondary Packaging Pouches in Asia-Pacific, 2022-2035 (Billion Units)
Figure 11.26 Demand for Pharmaceutical Secondary Packaging in MENA, 2022-2035 (Billion Units)
Figure 11.27 Demand for Pharmaceutical Secondary Packaging Boxes in MENA, 2022-2035 (Billion Units)
Figure 11.28 Demand for Pharmaceutical Secondary Packaging Cartons in MENA, 2022-2035 (Billion Units)
Figure 11.29 Demand for Pharmaceutical Secondary Packaging Pouches in MENA, 2022-2035 (Million Units)
Figure 11.30 Demand for Pharmaceutical Secondary Packaging in Latin America, 2022-2035 (Billion Units)
Figure 11.31 Demand for Pharmaceutical Secondary Packaging Boxes in Latin America, 2022-2035 (Billion Units)
Figure 11.32 Demand for Pharmaceutical Secondary Packaging Cartons in Latin America, 2022-2035 (Billion Units)
Figure 11.33 Demand for Pharmaceutical Secondary Packaging Pouches in Latin America, 2022-2035 (Million Units)
Figure 11.34 Demand for Pharmaceutical Secondary Packaging in Rest of the World, 2022-2035 (Billion Units)
Figure 11.35 Demand for Pharmaceutical Secondary Packaging Boxes in Rest of the World, 2022-2035 (Billion Units)
Figure 11.36 Demand for Pharmaceutical Secondary Packaging Cartons in Rest of the World, 2022-2035 (Billion Units)
Figure 11.37 Demand for Pharmaceutical Secondary Packaging Pouches in Rest of the World, 2022-2035 (Million Units)
Figure 12.1 Global Pharmaceutical Secondary Packaging Market, 2022-2035 (USD Billion)
Figure 12.2 Pharmaceutical Secondary Packaging Market: Distribution by Type of Secondary Packaging, 2022 and 2035 (USD Billion)
Figure 12.3 Global Pharmaceutical Secondary Packaging Market for Boxes, 2022-2035 (USD Billion)
Figure 12.4 Global Pharmaceutical Secondary Packaging Market for Cartons, 2022-2035 (USD Billion)
Figure 12.5 Global Pharmaceutical Secondary Packaging Market for Pouches, 2022-2035 (USD Billion)
Figure 12.6 Pharmaceutical Secondary Packaging Market: Distribution by Type of Primary Packaging Packed, 2022 and 2035 (USD Billion)
Figure 12.7 Pharmaceutical Secondary Packaging Market for Ampoules, 2022-2035 (USD Billion)
Figure 12.8 Pharmaceutical Secondary Packaging Market for Blister Packs, 2022-2035 (USD Billion)
Figure 12.9 Pharmaceutical Secondary Packaging Market for Bottles, 2022-2035 (USD Billion)
Figure 12.10 Pharmaceutical Secondary Packaging Market for Cartridges, 2022-2035 (USD Billion)
Figure 12.11 Pharmaceutical Secondary Packaging Market for Syringes, 2022-2035 (USD Billion)
Figure 12.12 Pharmaceutical Secondary Packaging Market for Vials, 2022-2035 (USD Billion)
Figure 12.13 Pharmaceutical Secondary Packaging Market: Distribution by Geography, 2022 and 2035 (USD Billion)
Figure 12.14 Pharmaceutical Secondary Packaging Market in North America, 2022 and 2035 (USD Billion)
Figure 12.15 Pharmaceutical Secondary Packaging Market for Boxes in North America, 2022-2035 (USD Billion)
Figure 12.16 Pharmaceutical Secondary Packaging Market for Cartons in North America, 2022-2035 (USD Billion)
Figure 12.17 Pharmaceutical Secondary Packaging Market for Pouches in North America, 2022-2035 (USD Billion)
Figure 12.18 Pharmaceutical Secondary Packaging Market in Europe, 2022 and 2035 (USD Billion)
Figure 12.19 Pharmaceutical Secondary Packaging Market for Boxes in Europe, 2022-2035 (USD Billion)
Figure 12.20 Pharmaceutical Secondary Packaging Market for Cartons in Europe, 2022-2035 (USD Billion)
Figure 12.21 Pharmaceutical Secondary Packaging Market for Pouches in Europe, 2022-2035 (USD Billion)
Figure 12.22 Pharmaceutical Secondary Packaging Market in Asia-Pacific, 2022 and 2035 (USD Billion)
Figure 12.23 Pharmaceutical Secondary Packaging Market for Boxes in Asia-Pacific, 2022-2035 (USD Billion)
Figure 12.24 Pharmaceutical Secondary Packaging Market for Cartons in Asia-Pacific, 2022-2035 (USD Billion)
Figure 12.25 Pharmaceutical Secondary Packaging Market for Pouches in Asia-Pacific, 2022-2035 (USD Billion)
Figure 12.26 Pharmaceutical Secondary Packaging Market in MENA, 2022 and 2035 (USD Billion)
Figure 12.27 Pharmaceutical Secondary Packaging Market for Boxes in MENA, 2022-2035 (USD Billion)
Figure 12.28 Pharmaceutical Secondary Packaging Market for Cartons in MENA, 2022-2035 (USD Billion)
Figure 12.29 Pharmaceutical Secondary Packaging Market for Pouches in MENA, 2022-2035 (USD Billion)
Figure 12.30 Pharmaceutical Secondary Packaging Market in Latin America, 2022 and 2035 (USD Billion)
Figure 12.31 Pharmaceutical Secondary Packaging Market for Boxes in Latin America, 2022-2035 (USD Billion)
Figure 12.32 Pharmaceutical Secondary Packaging Market for Cartons in Latin America, 2022-2035 (USD Billion)
Figure 12.33 Pharmaceutical Secondary Packaging Market for Pouches in Latin America, 2022-2035 (USD Billion)
Figure 12.34 Pharmaceutical Secondary Packaging Market in Rest of the World, 2022 and 2035 (USD Billion)
Figure 12.35 Pharmaceutical Secondary Packaging Market for Boxes in Rest of the World, 2022-2035 (USD Billion)
Figure 12.36 Pharmaceutical Secondary Packaging Market for Cartons in Rest of the World, 2022-2035 (USD Billion)
Figure 12.37 Pharmaceutical Secondary Packaging Market for Pouches in Rest of the World, 2022-2035 (USD Billion)
Figure 13.1 Concluding Remarks: Overall Market Landscape
Figure 13.2 Concluding Remarks: Partnerships and Collaborations
Figure 13.3 Concluding Remarks: Recent Expansions
Figure 13.4 Concluding Remarks: Demand Analysis
Figure 13.5 Concluding Remarks: Market Forecast
Table 4.1 List of Pharmaceutical Secondary Packaging Providers
Table 4.2 Pharmaceutical Secondary Packaging Providers: Information on Type of Secondary Packaging Offered
Table 4.3 Pharmaceutical Secondary Packaging Providers: Information on Types of Additional Service Offered
Table 6.1 Leading Pharmaceutical Secondary Packaging Service Providers in North America
Table 6.2 Catalent: Company Snapshot
Table 6.3 Catalent: Pharmaceutical Secondary Packaging Offerings
Table 6.4 Catalent: Recent Developments and Future Outlook
Table 6.5 Patheon: Company Snapshot
Table 6.6 Patheon: Pharmaceutical Secondary Packaging Offerings
Table 6.7 Patheon: Recent Developments and Future Outlook
Table 6.8 PCI Pharma Services: Company Snapshot
Table 6.9 PCI Pharma Services: Pharmaceutical Secondary Packaging Offerings
Table 6.10 PCI Pharma Services: Recent Developments and Future Outlook
Table 6.11 Pfizer CentreOne: Company Snapshot
Table 6.12 Pfizer CentreOne: Pharmaceutical Secondary Packaging Offerings
Table 6.13 Pfizer CentreOne: Recent Developments and Future Outlook
Table 6.14 Sharp: Company Snapshot
Table 6.15 Sharp: Pharmaceutical Secondary Packaging Offerings
Table 6.16 Sharp: Recent Developments and Future Outlook
Table 7.1 Leading Pharmaceutical Secondary Packaging Service Providers in Europe
Table 7.2 Almac Group: Company Snapshot
Table 7.3 Almac Group: Pharmaceutical Secondary Packaging Offerings
Table 7.4 Almac Group: Recent Developments and Future Outlook
Table 7.5 Central Pharma: Company Snapshot
Table 7.6 Central Pharma: Pharmaceutical Secondary Packaging Offerings
Table 7.7 Central Pharma: Recent Developments and Future Outlook
Table 7.8 CordenPharma: Company Snapshot
Table 7.9 CordenPharma: Pharmaceutical Secondary Packaging Offerings
Table 7.10 CordenPharma: Recent Developments and Future Outlook
Table 7.11 Eurofins CDMO: Company Snapshot
Table 7.12 Eurofins CDMO: Pharmaceutical Secondary Packaging Offerings
Table 7.13 Eurofins CDMO: Recent Developments and Future Outlook
Table 7.14 Tjoapack: Company Snapshot
Table 7.15 Tjoapack: Pharmaceutical Secondary Packaging Offerings
Table 7.16 Tjoapack: Recent Developments and Future Outlook
Table 8.1 Leading Pharmaceutical Secondary Packaging Service Providers in Asia-Pacific
Table 8.2 ABS: Company Snapshot
Table 8.3 ABS: Pharmaceutical Secondary Packaging Offerings
Table 8.4 ABS: Recent Developments and Future Outlook
Table 8.5 Bushu Pharma: Company Snapshot
Table 8.6 Bushu Pharma: Pharmaceutical Secondary Packaging Offerings
Table 8.7 Bushu Pharma: Recent Developments and Future Outlook
Table 8.8 CMIC: Company Snapshot
Table 8.9 CMIC: Pharmaceutical Secondary Packaging Offerings
Table 8.10 CMIC: Recent Developments and Future Outlook
Table 8.11 Kishore Group: Company Snapshot
Table 8.12 Kishore Group: Pharmaceutical Secondary Packaging Offerings
Table 8.13 Kishore Group: Recent Developments and Future Outlook
Table 8.14 Prince Art Packages: Company Snapshot
Table 8.15 Prince Art Packages: Pharmaceutical Secondary Packaging Offerings
Table 8.16 Prince Art Packages: Recent Developments and Future Outlook
Table 9.1 Pharmaceutical Secondary Packaging Providers: List of Partnerships and Collaborations, 2018-2021
Table 10.1 Pharmaceutical Secondary Packaging Providers: Recent Expansions, 2018-2022
Table 15.1 Pharmaceutical Secondary Packaging Providers: Distribution by Year of Establishment
Table 15.2 Pharmaceutical Secondary Packaging Providers: Distribution by Company Size
Table 15.3 Pharmaceutical Secondary Packaging Providers: Distribution by Location of
Table 15.4 Pharmaceutical Secondary Packaging Providers: Distribution by Location of Headquarters (Country-wise)
Table 15.5 Pharmaceutical Secondary Packaging Providers: Distribution by Company Size and Location of Headquarters
Table 15.6 Pharmaceutical Secondary Packaging Providers: Distribution by Scale of Operation
Table 15.7 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Service Provider
Table 15.8 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Secondary Packaging Offered
Table 15.9 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Primary Packaging Packed
Table 15.10 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Molecule Packed
Table 15.11 Pharmaceutical Secondary Packaging Providers: Distribution by Type of Finished Dosage Form Packed
Table 15.12 Pharmaceutical Secondary Packaging Providers: Distribution by Types of Additional Services Offered
Table 15.13 Partnerships and Collaborations: Cumulative Year-wise Trend, 2018-2021
Table 15.14 Partnerships and Collaborations: Distribution by Type of Partnership
Table 15.15 Partnerships and Collaborations: Distribution by Year and Type of Partnership
Table 15.16 Partnerships and Collaborations: Distribution by Type of Partnership, 2018-2019 and 2020-2021
Table 15.17 Partnerships and Collaborations: Distribution by Type of Molecule Packed
Table 15.18 Partnerships and Collaborations: Distribution by Type of Finished Dosage Form Packed
Table 15.19 Most Active Players: Distribution by Number of Partnerships
Table 15.20 Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
Table 15.21 Partnerships and Collaborations: Distribution of International and Local Deals
Table 15.22 Recent Expansions: Cumulative Year-wise Trend, 2018-2022
Table 15.23 Recent Expansions: Distribution by Type of Expansion
Table 15.24 Recent Expansions: Distribution by Scale of Operation
Table 15.25 Recent Expansions: Distribution by Type of Expansion and Scale of Operation
Table 15.26 Recent Expansions: Distribution by Type of Primary Packaging Packed
Table 15.27 Recent Expansions: Distribution by Type of Molecule Packed
Table 15.28 Recent Expansions: Distribution by Type of Expansion and Type of Molecule Packed
Table 15.29 Recent Expansions: Distribution by Type of Finished Dosage Form Packed
Table 15.30 Recent Expansions: Distribution by Company Size and Location of Headquarters
Table 15.31 Recent Expansions: Distribution by Location of Expanded Facility
Table 15.32 Recent Expansions: Distribution by Type of Expansion and Location of Expanded Facility
Table 15.33 Most Active Players: Distribution by Number of Recent Expansions
Table 15.34 Recent Expansions: Year-wise Trend by Geography, 2018-2022
Table 15.35 Recent Expansions: Country-wise Distribution
Table 15.36 Global Demand for Pharmaceutical Secondary Packaging, 2022-2035 (Billion Units)
Table 15.37 Global Demand for Pharmaceutical Secondary Packaging: Distribution by Type of Secondary Packaging, 2022-2035 (Billion Units)
Table 15.38 Global Demand for Pharmaceutical Secondary Packaging Boxes, 2022-2035 (Billion Units)
Table 15.39 Global Demand for Pharmaceutical Secondary Packaging Cartons, 2022-2035 (Billion Units)
Table 15.40 Global Demand for Pharmaceutical Secondary Packaging Pouches, 2022-2035 (Billion Units)
Table 15.41 Global Demand for Pharmaceutical Secondary Packaging: Distribution by Type of Primary Packaging Packed, 2022 and 2035 (Billion Units)
Table 15.42 Demand for Pharmaceutical Secondary Packaging of Ampoules, 2022-2035 (Billion Units)
Table 15.43 Demand for Pharmaceutical Secondary Packaging of Blister Packs, 2022-2035 (Billion Units)
Table 15.44 Demand for Pharmaceutical Secondary Packaging of Bottles, 2022-2035 (Billion Units)
Table 15.45 Demand for Pharmaceutical Secondary Packaging of Cartridges, 2022-2035 (Billion Units)
Table 15.46 Demand for Pharmaceutical Secondary Packaging of Syringes, 2022-2035 (Billion Units)
Table 15.47 Demand for Pharmaceutical Secondary Packaging of Vials, 2022-2035 (Billion Units)
Table 15.48 Global Demand for Pharmaceutical Secondary Packaging: Distribution by Geography, 2022 and 2035 (Billion Units)
Table 15.49 Demand for Pharmaceutical Secondary Packaging in North America, 2022-2035 (Billion Units)
Table 15.50 Demand for Pharmaceutical Secondary Packaging Boxes in North America, 2022-2035 (Billion Units)
Table 15.51 Demand for Pharmaceutical Secondary Packaging Cartons in North America, 2022-2035 (Billion Units)
Table 15.52 Demand for Pharmaceutical Secondary Packaging Pouches in North America, 2022-2035 (Billion Units)
Table 15.53 Demand for Pharmaceutical Secondary Packaging in Europe, 2022-2035 (Billion Units)
Table 15.54 Demand for Pharmaceutical Secondary Packaging Boxes in Europe, 2022-2035 (Billion Units)
Table 15.55 Demand for Pharmaceutical Secondary Packaging Cartons in Europe, 2022-2035 (Billion Units)
Table 15.56 Demand for Pharmaceutical Secondary Packaging Pouches in Europe, 2022-2035 (Billion Units)
Table 15.57 Demand for Pharmaceutical Secondary Packaging in Asia-Pacific, 2022-2035 (Billion Units)
Table 15.58 Demand for Pharmaceutical Secondary Packaging Boxes in Asia-Pacific, 2022-2035 (Billion Units)
Table 15.59 Demand for Pharmaceutical Secondary Packaging Cartons in Asia-Pacific, 2022-2035 (Billion Units)
Table 15.60 Demand for Pharmaceutical Secondary Packaging Pouches in Asia-Pacific, 2022-2035 (Billion Units)
Table 15.61 Demand for Pharmaceutical Secondary Packaging in MENA, 2022-2035 (Billion Units)
Table 15.62 Demand for Pharmaceutical Secondary Packaging Boxes in MENA, 2022-2035 (Billion Units)
Table 15.63 Demand for Pharmaceutical Secondary Packaging Cartons in MENA, 2022-2035 (Billion Units)
Table 15.64 Demand for Pharmaceutical Secondary Packaging Pouches in MENA, 2022-2035 (Million Units)
Table 15.65 Demand for Pharmaceutical Secondary Packaging in Latin America, 2022-2035 (Billion Units)
Table 15.66 Demand for Pharmaceutical Secondary Packaging Boxes in Latin America, 2022-2035 (Billion Units)
Table 15.67 Demand for Pharmaceutical Secondary Packaging Cartons in Latin America, 2022-2035 (Billion Units)
Table 15.68 Demand for Pharmaceutical Secondary Packaging Pouches in Latin America, 2022-2035 (Million Units)
Table 15.69 Demand for Pharmaceutical Secondary Packaging in Rest of the World, 2022-2035 (Billion Units)
Table 15.70 Demand for Pharmaceutical Secondary Packaging Boxes in Rest of the World, 2022-2035 (Billion Units)
Table 15.71 Demand for Pharmaceutical Secondary Packaging Cartons in Rest of the World, 2022-2035 (Billion Units)
Table 15.72 Demand for Pharmaceutical Secondary Packaging Pouches in Rest of the World, 2022-2035 (Million Units)
Table 15.73 Global Pharmaceutical Secondary Packaging Market, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.74 Pharmaceutical Secondary Packaging Market: Distribution by Type of Secondary Packaging, 2022 and 2035 (USD Billion)
Table 15.75 Global Pharmaceutical Secondary Packaging Market for Boxes, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.76 Global Pharmaceutical Secondary Packaging Market for Cartons, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.77 Global Pharmaceutical Secondary Packaging Market for Pouches, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.78 Pharmaceutical Secondary Packaging Market: Distribution by Type of Primary Packaging Packed, 2022 and 2035 (USD Billion)
Table 15.79 Pharmaceutical Secondary Packaging Market for Ampoules, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.80 Pharmaceutical Secondary Packaging Market for Blister Packs, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.81 Pharmaceutical Secondary Packaging Market for Bottles, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.82 Pharmaceutical Secondary Packaging Market for Cartridges, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.83 Pharmaceutical Secondary Packaging Market for Syringes, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.84 Pharmaceutical Secondary Packaging Market for Vials, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.85 Pharmaceutical Secondary Packaging Market: Distribution by Geography, 2022 and 2035 (USD Billion)
Table 15.86 Pharmaceutical Secondary Packaging Market in North America, 2022 and 2035 (USD Billion)
Table 15.87 Pharmaceutical Secondary Packaging Market for Boxes in North America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.88 Pharmaceutical Secondary Packaging Market for Cartons in North America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.89 Pharmaceutical Secondary Packaging Market for Pouches in North America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.90 Pharmaceutical Secondary Packaging Market in Europe, 2022 and 2035 (USD Billion)
Table 15.91 Pharmaceutical Secondary Packaging Market for Boxes in Europe, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.92 Pharmaceutical Secondary Packaging Market for Cartons in Europe, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.93 Pharmaceutical Secondary Packaging Market for Pouches in Europe, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.94 Pharmaceutical Secondary Packaging Market in Asia-Pacific, 2022 and 2035 (USD Billion)
Table 15.95 Pharmaceutical Secondary Packaging Market for Boxes in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.96 Pharmaceutical Secondary Packaging Market for Cartons in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.97 Pharmaceutical Secondary Packaging Market for Pouches in Asia-Pacific, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.98 Pharmaceutical Secondary Packaging Market in MENA, 2022 and 2035 (USD Billion)
Table 15.99 Pharmaceutical Secondary Packaging Market for Boxes in MENA, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.100 Pharmaceutical Secondary Packaging Market for Cartons in MENA, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.101 Pharmaceutical Secondary Packaging Market for Pouches in MENA, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.102 Pharmaceutical Secondary Packaging Market in Latin America, 2022 and 2035 (USD Billion)
Table 15.103 Pharmaceutical Secondary Packaging Market for Boxes in Latin America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.104 Pharmaceutical Secondary Packaging Market for Cartons in Latin America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.105 Pharmaceutical Secondary Packaging Market for Pouches in Latin America, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.106 Pharmaceutical Secondary Packaging Market in Rest of the World, 2022 and 2035 (USD Billion)
Table 15.107 Pharmaceutical Secondary Packaging Market for Boxes in Rest of the World, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.108 Pharmaceutical Secondary Packaging Market for Cartons in Rest of the World, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
Table 15.109 Pharmaceutical Secondary Packaging Market for Pouches in Rest of the World, Conservative, Base and Optimistic Scenarios, 2022-2035 (USD Billion)
The following companies / institutes / government bodies and organizations have been mentioned in this report.
PRICING DETAILS
Discounts available for multiple report purchases
sales@rootsanalysis.com
YOU MAY ALSO LIKE
SUBSCRIBE TO INDUSTRY UPDATES